Does Greater Long-Term IOP Variability Increase Probability of Primary Open Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS)? M.O. Gordon,

Slides:



Advertisements
Similar presentations
Il controllo circadiano della pressione intraoculare: implicazioni farmacologiche N. ORZALESI, P. FOGAGNOLO Università degli Studi di Milano Ospedale San.
Advertisements

Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Clinical Guidance and Monitoring for Change Cecilia Fenerty MD FRCOphth.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Serum Lipids and Proliferative Diabetic Retinopathy Klein BEK, Myers CE, Howard.
Henry C. Ginsberg, MD College of Physicians & Surgeons, Columbia University, New York For The ACCORD Study Group.
1 Intraocular Pressure Spikes in Difluprednate Ophthalmic Emulsion 0.05% for Postoperative Cataract Inflammation by Melissa M. Cable, FAAO, FACS Discover.
Anterior Chamber Depth, Iridocorneal Angle Width, and Intraocular Pressure Changes After Phacoemulsification: Narrow vs Open Iridocorneal Angles Huang.
The Diabetic Retinopathy Clinical Research Network Repeated Intravitreous Ranibizumab Injections for DME and Risk of Sustained IOP Elevation or Need for.
4/19/2017 Managing Patients With Ocular Hypertension Results From The Ocular Hypertension Treatment Study (OHTS) The American Glaucoma Society Michael.
Henry N. Ginsberg, MD College of Physicians & Surgeons, Columbia University, New York For The ACCORD Study Group.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Aref.
OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
November 2006 Prediction Model Template from OHTS-EGPS Pooled Analyses Today’s version is November 14.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Retinal Nerve Fiber Layer Loss and Quality of Life in Glaucoma Gracitelli CPB,
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Intraocular Pressure Risk Factors Parekh A, Srivastava S, Bena J, Albini T, Nguyen.
The Ocular Hypertension Treatment Study (OHTS) Supported by the National Eye Institute, National Center on Minority Health and Health Disparities, Research.
Will my Glaucoma patient lose vision ?
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.
Black Patients Die Earlier after Surgery for Esophageal Cancer Andrea S. Wolf, MD, MPH, Emanuela Taioli MD, PhD, Marlene Camacho-Rivera, ScD, MPH, Andrew.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
QUANTITATING THE IMPACT OF CLINICAL AND BASIC SCIENCE RESEARCH POSTER #2469 M. O. GORDON, C. SARLI, E. K. DUBINSKY, E. LONG, C. LA RUE, M. A. KASS, AND.
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Impact of age and comorbidities on treatment effect, tolerance and toxicity in metastatic colorectal cancer (mCRC) patients (pts) treated on CALGB
Outcomes Following Adjuvant 5-FU based Treatment (AT) for Colon Cancer vs Impact on Recurrence Rate, Time from Recurrence to Death.
Effect of Corneal Thickness on Selective Laser Trabeculoplasty to Decrease Intraocular Pressure as Primary or Secondary Treatment of Glaucoma ASCRS 2010.
Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
Effect of Race on Selective Laser Trabeculoplasty  1st author has no financial interest in the subject matter of this poster.  2nd and 3rd co-authors.
Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.
1 Slides Shown at FDA Advisory Committee Eyetech Pharmaceuticals Pfizer, Inc. Dermatologic and Ophthalmic Drugs Advisory Committee Meeting 27 August 2004.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Rate of Visual Field Progression in Eyes With Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study De Moraes CG, Demirel S, Gardiner SK, et.
The Ocular Hypertension Treatment Study Group (OHTS)
Effect of East Asian Race on Selective Laser Trabeculoplasty ASCRS 2011 Minerva Kim Johns Hopkins University Lawrence F. Jindra, MD Columbia University.
Effect of Refractive State on Selective Laser Trabeculoplasty ASCRS 2011 Kevin Lai Stony Brook University School of Medicine Elaine M. Miglino Floral Park.
Prospective Randomized Comparison of Conventional Stress Echocardiography with Real Time Perfusion Stress Echocardiography in Predicting Clinical Outcome.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Baseline topographic optic disc measurements are associated with the development of POAG: The CSLO Ancillary Study to the OHTS Linda M Zangwill Robert.
Three-Year Outcomes of the Surgery for Trichiasis, Antibiotics to Prevent Recurrence Trial Woreta F, Munoz B, Gower E, Alemayehu W, West SK. Three-year.
Elmira Baghdasaryan1,2, M.D. Sophie X. Deng1, M.D., Ph.D.
Clinical Effectiveness Of Contrast Sensitivity Function In Patients With Primary Open Angle Glaucoma (POAG) And Ocular Hypertension (OHT ) MOUSUMI SAIKIA.
Reducing Surveillance Bias in Adverse Events Reporting in an Unmasked Treatment Trial Mae Gordon, Julia Beiser, Patricia Morris, J. Philip Miller, Michael.
The Royal Victorian Eye and Ear Hospital 24-hour eye pressure and glaucoma Dr Simon Skalicky FRANZCO, MPhil, MMed (Ophthal Sci), MBBS (Hons 1) Visiting.
Six-Year Longevity of Selective Laser Trabeculoplasty as Primary Therapy in Patients with Glaucoma ASCRS 2009 Lawrence F. Jindra, MD Columbia University.
Effect of Previous Argon Laser Trabeculoplasty on Selective Laser Trabeculoplasty ASCRS 2011 Lawrence F. Jindra, MD Columbia University Winthrop University.
Differential Effect of Glaucoma Medications on Dry Eye Incidence Scott D. Walter, MD, MS, Sarah R. Wellik, MD, William J. Feuer, MS, Anat Galor, MD, MSPH.
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
The Efficacy and Safety of the Low Intensity Ultrasound Treatment in Patients with Open Angle Glaucoma Hyoung Won Bae, Gong Je Seong, Chan Yun Kim Institute.
IMPACT OF CATARACT SURGERY UPON INTRAOCULAR PRESURE CONTROL IN GLAUCOMA PATIENTS Crenguta Feraru, Anca Pantalon “Gr.T. Popa” University of Medicine and.
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
ACCORD Design and Baseline Characteristics
Ophthalmology – Raised IOP Referrals (Adults only)
Characteristics of Primary Angle-Closure Glaucoma Patients with Normal Intraocular Pressure at the First Visit Won Hyuk Oh1, Bum Gi Kim1, Joo Hwa Lee2.
Safety of medication reduction for Primary Angle Closure (PAC) –
Purpose Results Results Methods Conclusion
Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Year 1 Results Lisa A. Hark, PhD, RD; Michael Waisbourd, MD; Kamran Rahmatnejad, MD;
Jan B. Pietzsch1, Benjamin P. Geisler1, Murray D. Esler 2
Risk stratification and calculators
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
JAMA Ophthalmology Journal Club Slides: Effect of Oral Voriconazole on Fungal Keratitis Prajna NV, TKrishnan T, Rajaraman R, et al; Mycotic Ulcer Treatment.
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Adults in California and New York Reported Lower Rates of Cost-Related Access Problems Than Those in Florida and Texas Percent of adults ages 19–64 U.S.
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
Winthrop University Hospital
The Effect of Corneal Thickness on Ocular Drug Penetration
Presentation transcript:

Does Greater Long-Term IOP Variability Increase Probability of Primary Open Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS)? M.O. Gordon, J.A. Beiser, J. Miller, M. Kass, F. Gao The Ocular Hypertension Treatment Study Group (OHTS) May 3, 2011 ARVO Ft. Lauderdale, FL National Eye Institute, National Center for Minority Health and Health Disparities, NIH grants EY09307, EY09341, Unrestricted Grant from Research to Prevent Blindness, Merck Research Laboratories and Pfizer, Inc.

Sources of Support  NIH grants National Eye InstituteNational Eye Institute National Center for Minority Health and Health Disparities, EY09307, EY09341National Center for Minority Health and Health Disparities, EY09307, EY09341  Unrestricted Grants Research to Prevent BlindnessResearch to Prevent Blindness Merck Research LaboratoriesMerck Research Laboratories Pfizer, Inc.Pfizer, Inc.

Question? Is greater long-term IOP variability an independent factor for the risk of primary open angle glaucoma (POAG) in the OHTS? Is greater long-term IOP variability an independent factor for the risk of primary open angle glaucoma (POAG) in the OHTS?

Patient found eligible for OHTS Eligible untreated IOPs on 2 visits 2 sets of normal & reliable HVFs per VFRC Optic discs judged normal by ODRC Medication Topical treatment to lower IOP 20% and IOP < 24 mm Hg n=817Observation No topical treatment to lower IOP n=819 Randomization Monitoring Humphrey 30-2 q6 months Stereoscopic disc photos annually Adjust therapy if target not met

Analysis Dataset Baseline data: Age, CCT, PSD, VCD Baseline data: Age, CCT, PSD, VCD F/up of >4 visits ( 4 visits (< 3 unstable results) Eye to develop POAG or random eye Eye to develop POAG or random eye Censored data after: Censored data after: Initiation of topical hypotensive medication Eye surgery POAG

IOP Variables POAG eye or random eye Mean f/up IOP: Mean f/up IOP: Baseline & 6 mo. follow-up in Obs. group Standard deviation of f/up IOP Standard deviation of f/up IOP Maximum f/up IOP Maximum f/up IOP Range of f/up IOP Range of f/up IOP (maximum – minimum)

Definition of POAG 3 consecutive reliable, abnormal visual fields and/or 2 consecutive stereo-optic disc photographs showing progression per Reading Center 3 consecutive reliable, abnormal visual fields and/or 2 consecutive stereo-optic disc photographs showing progression per Reading Center Masked Endpoint Committee (DH, EH, RP) adjudicated if change could be attributable to POAG. Masked Endpoint Committee (DH, EH, RP) adjudicated if change could be attributable to POAG. Optic disc progression also had to be “clinically significant” (JND not adequate) Optic disc progression also had to be “clinically significant” (JND not adequate)

Result: Analysis Dataset Median 16 visits Median 16 visits 84% (687 of 819) Observation pts. 84% (687 of 819) Observation pts. (no CCT, censored< 4 visits, < 4 visits) 12% (84 of 687) pts developed POAG in 1 or both eyes 12% (84 of 687) pts developed POAG in 1 or both eyes

Description of F/up IOP Variables N=687 Obs. pts. Mean + SD Mean IOP Mean IOP SD IOP SD IOP Max IOP Max IOP Range IOP Range IOP

Correlation of IOP Variables Mean IOP SDMaxRange Mean IOP SD IOP Max IOP Range IOP-----

Analysis Plan Cox proportional hazards model for each measure of IOP variability Cox proportional hazards model for each measure of IOP variability Univariate Cox proportional hazards model Univariate Cox proportional hazards model Multivariable Cox proportional hazards models: Ag e, CCT, mean IOP, VCD, PSD + Var Multivariable Cox proportional hazards models: Ag e, CCT, mean IOP, VCD, PSD + Var C statistic for predictive accuracy C statistic for predictive accuracy Calibration chi-square for model fit Calibration chi-square for model fit

Quartiles Mean IOP (baseline & f/up) Obs. Group Cox Proportional Hazards Quartiles Mean IOP (baseline & f/up) Obs. Group Cox Proportional Hazards UnivariateMultivariable + Mean IOP Quartiles HR95% CIHR95% CI Q1: [15.5, 21.8)* Mean= N/A1.0N/A Q2: [21.9, 23.8) Mean= Q3: [23.9,26.0) Mean= Q4: [26.0,35.0] Mean= P-Value< C-statistic and Calibration χ and 4.48 *First quartile used as the reference level. +Multi-variable model includes baseline age, CCT, PSD, VCD and mean IOP.

Quartiles IOP SD Obs. group Cox Proportional Hazards UnivariateMultivariable IOP Standard Deviation HR95% CIHR95% CI Q1: [0.67, 1.88)* Mean=1.51.0N/A1.0N/A Q2: [1.89, 2.36) Mean= Q3: [2.37, 2.99) Mean= Q4: [3.0, 9.25] Mean= P-Value C-statistic and Calibration χ and 8.57 *First quartile used as the reference level. +Multi-variable model includes baseline age, CCT, PSD, VCD, mean follow up IOP, and IOP SD.

Quartiles IOP Max Obs. group Cox Proportional Hazards UnivariateMultivariable IOP Maximum HR95% CIHR95% CI Q1: [19.0, 25.6)* Mean= N/A1.0N/A Q2: [25.7, 27.6) Mean= Q3: [27.7, 30.2) Mean= Q4: [30.3, 51.0] Mean= P-Value< C-statistic and Calibration χ and 4.53 *First quartile was used as the reference level +Multi-variable model includes baseline age, CCT, PSD, VCD, mean follow up IOP, and IOP Max.

Quartiles IOP Range Obs. group Cox Proportional Hazards UnivariateMultivariable IOP Range HR95% CIHR95% CI Q1: [2.0, 6.2)* Mean=4.81.0N/A1.0N/A Q2: [6.2, 8.3) Mean= – – 3.8 Q3: [8.3, 10.2) Mean= – – 2.3 Q4: [10.2, 27.3] Mean= – – 2.1 P-Value C-statistic and Calibration χ and 4.74 *First quartile was used as the reference level +Multi-variable model includes baseline age, CCT, PSD, VCD, mean follow up IOP, and IOP range.

Summary (replicated w > 4,5,6 visits in Obs. group) Multivariable P-ValueC Statistic Calibration Chi-Square Mean IOP< SD IOP Max IOP Range IOP

Percent POAG (n=84/687) by Quartile of Mean IOP and SD IOP Interaction of mean IOP * SD IOP is not statistically significant < 21.9 >21.9 to <23.9 > 23.9 to <26.0 > 26.0 <1.9>1.9 to <2.4>2.4 to <3.0 > 3.0 Standard Deviation of f/up IOP 3%4%5% 2%8% 4% 6%19%6%15% 22%24%29%36% 0% Mean f/up IOP (mm Hg)

Conclusions Higher long-term IOP variability (SD) is an independent risk factor for the development of POAG in the Obs. Group in the OHTS Higher long-term IOP variability (SD) is an independent risk factor for the development of POAG in the Obs. Group in the OHTS SD IOP does not improve predictive accuracy of model with age, mean f/up IOP, CCT, VCD and PSD SD IOP does not improve predictive accuracy of model with age, mean f/up IOP, CCT, VCD and PSD SD IOP difficult to measure, uncertain value in clinical practice SD IOP difficult to measure, uncertain value in clinical practice

OHTS Clinical Centers  Bascom Palmer Eye Institute  Baylor Eye Clinic  Charles R. Drew University  Devers Eye Institute  Emory University Eye Center  Eye Associates of Washington, DC  Eye Consultants of Atlanta  Eye Doctors of Washington  Eye Physicians and Surgeons of Atlanta  Glaucoma Care Center  Great Lakes Ophthalmology  Henry Ford Hospitals  Johns Hopkins University  Jules Stein Eye Institute, UCLA  Kellogg Eye Center  Kresge Eye Institute  Krieger Eye Institute  Maryland Center for Eye Care  Mayo Clinic/Foundation  New York Eye & Ear Infirmary  Ohio State University  Salus University  Scheie Eye Institute  University of California, Davis  University of California, San Diego  University of California, San Francisco  University of Louisville  University Suburban Health Center  Washington Eye Physicians & Surgeons  Washington University, St. Louis

OHTS Resource Centers Study Chairman’s Office & Coordinating Center Washington University St. Louis, MO Visual Field Reading Center University of California, Davis Sacramento, CA Optic Disc Reading Center Bascom Palmer Eye Institute University of Miami Miami, FL

QUESTIONS? Thank-you!